Vaxtex Cotfab share news, announcements and annual reports
NSE: VCLTextiles & ApparelsSmall Cap
Vaxtex Cotfab Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2020 · Issue price ₹24
Last close ₹1.59down ₹0.08 (4.79%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹1.67.
30 Oct: open ₹1.66, high ₹1.66, low ₹1.59
52-week range of traded prices to 30 Oct 2026
₹0.87Low, 10 Nov 2025₹2.66High, 10 Dec 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹29 Cr3,792nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.56
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.23
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,36,958
Vaxtex Cotfab disputes and clarifications
20 filed, newest first.
Jun 2022
22 Jun · Legal
The exchange asked on 21 Jun 2022
May 2022
9 May · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
Apr 2022
Mar 2022
25 Mar · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 25-Mar-2022 informing about appointment of directors.On the basis of aforesaid announcement, the Company is required to provide/clarify the following:1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
Feb 2022
1 Feb · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 22-Jan-2022, regarding appointment of Mr. Pranav Vajani as Independent Director of the Company.On basis of above the Company is required to clarify following -1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director);3. Confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018.The response of the Company is awaited.
Jan 2022
11 Jan · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 07-Jan-2022, regarding Outcome of Board Meeting held on 7th January, 2022. On basis of above the Company is required to clarify following: 1. Whether bonus is out of free reserves created out of profits or share premium account;2. Details of share capital - pre and post bonus issue;3. Free reserves and/ or share premium required for implementing the bonus issue;4. Free reserves and/ or share premium available for capitalization and the date as on which such balance is available;5. Whether the figures are audited;6. Estimated date by which such bonus shares would be credited/dispatched.The response of the Company is awaited.
Jul 2021
2 Jul · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 30-Jun-2021, regarding Appointment of Ms Ziral Soni as Independent Director of the company & Resignation of Mr. Dhaval Patel from the post of Independent Director of the Company. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment2. Brief profile (in case of appointment)3. No other material reasons other than provided4. Detailed Reasons for ResignationThe response of the Company is awaited.2 Jul · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
May 2021
Mar 2021
Feb 2021
Dec 2020
7 Dec · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited for the quarter ended 30-Sep-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Segment details not submitted The response of the Company is awaited.
Nov 2020
13 Nov · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 12-Nov-2020, regarding "Board meeting held on November 12, 2020."On basis of above the Company is required to clarify following:1. Date of appointment/cessation (as applicable) & term of appointment2. Brief profile (in case of appointment)3. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is awaited.4 Nov · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 03-Nov-2020, regarding resignation of Ms Poonam Panchal as Independent Director of the company w.e.f. November 02, 2020. On basis of above the Company is required to clarify following: 1. No other material reasons other than provided2. Detailed Reasons for ResignationThe response of the Company is awaited.
Oct 2020
Sep 2020
17 Sep · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
Aug 2020
10 Aug · Legal
Exchange has sought clarification from Vaxtex Cotfab Limited with respect to announcement dated 07-Aug-2020, regarding "Appointment of Ms PRIYANKA JOSHI as Company Secretary & Compliance Officer of the company w.e.f. August 10, 2020.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.